Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211
BLOOD CANCER JOURNAL（2015）
关键词
stem cells,immunology,oncology,cancer,haematology,fusion genes,therapy,apoptosis,hemopoiesis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要